Results 231 to 240 of about 5,331,188 (312)

Sociodemographic disparities and reasons for delayed healthcare among U.S. cancer survivors: an All of Us study. [PDF]

Support Care Cancer
Ng DQ, Zheng Z, Jemal A, Chan A, Islami F.   +4 more
europepmc   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Large fiber contribution to symptoms in chemotherapy-induced peripheral neuropathy in cancer survivors. [PDF]

Support Care Cancer
Levine JD, Cooper BA, Abrams G, Harris C, Paul SM, Conley YP, Hammer MJ, Miaskowski C.   +7 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Rising Risk of Subsequent Primary Cancers Among US Cancer Survivors, 2000-2021. [PDF]

Cancer Med
Cheng HG, Aduse-Poku L, Palesh O, Hong S.   +3 more
europepmc   +1 more source

Translating whole‐genome doubling into precision medicine in cancer

Molecular Oncology, EarlyView.
Whole‐genome doubling creates a WGD‐positive tumor state characterized by persistent chromosomal instability, karyotypic diversification, and cellular stress. These same biological pressures drive aggressive tumor evolution while exposing therapeutic vulnerabilities, providing a rationale for WGD‐informed precision medicine. Whole‐genome doubling (WGD)
Sejung Lee, Junghyeok Lim, Jinhyuk Bhin
wiley   +1 more source

Tailored Exercise Strategies and Mortality Among Breast Cancer Survivors.

JAMA Netw Open
Jayasekera J, Ergas IJ, Schneider J, Tian E, Wojcik KM, Roh JM, Vo JB, Kushi LH, Wilson OWA, McGee EE.   +9 more
europepmc   +1 more source

Anxiety, Depression, and Suicidality Among Testicular Cancer Survivors. [PDF]

Cancer Med
Meagher M, Riviere P, Nelson T, Morgan K, Puri D, Pandit K, Yodkhunnatham N, Yuen K, Taylor J, Herchenhorn D, Stewart T, Javier-Desloges J, Salmasi A, McKay R, Kern S, Millard F, Rose B, Bagrodia A.   +17 more
europepmc   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

Psychological flexibility, distress, and coping in ovarian cancer survivors. [PDF]

J Psychosoc Oncol
Telles R, Hosch A, Pennington KP, Schlumbrecht M, McGregor BA, Heron L, Zia S, Noble A, Goodheart MJ, Noonan M, Penedo FJ, Lutgendorf SK.   +11 more
europepmc   +1 more source